SCHEMBL9272210

SCHEMBL9272210

CCOC(=O)OCn1c(-c2ccc(C)cc2)nc(CN2CCN(C(c3ccccc3)c3ccccc3)CC2)c1C

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ LMNA P02545 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ OPRD1 P41143 1/20 0.43
▸ ATM Q13315 3/20 0.43
▸ CACNA2D1 P54289 1/20 0.41
▸ CACNA1B Q00975 1/20 0.41
▸ CACNB1 Q02641 1/20 0.41
▸ CACNA1C Q13936 1/20 0.41
▸ SLC6A9 P48067 1/20 0.40
▸ P2RX7 Q99572 1/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8989174 0.96 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19SMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL8989218 0.74 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19SMN1; SMN2LMNA
SCHEMBL9423066 0.73 CTSS (0.46) CYP3A4CYP2C9CYP2C19LMNANPSR1
Lifarizine SCHEMBL9494261 0.69 CYP3A4 (0.50) CYP3A4CYP2C9CYP2C19SMN1; SMN2LMNA
Lifarizine SCHEMBL676318 0.69 DRD2 (0.57) CYP3A4CYP2C9CYP2C19SMN1; SMN2LMNA
SCHEMBL8963806 0.68 CYP3A4 (0.56) CYP3A4CYP2C9CYP2C19SMN1; SMN2LMNA
Lifarizine SCHEMBL8963776 0.68 DRD2 (0.56) CYP3A4CYP2C9CYP2C19SMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL8989190 0.67 CTSS (0.56) CYP3A4CYP2C9CYP2C19LMNANPSR1
SCHEMBL8963681 0.67 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19SMN1; SMN2LMNA
SCHEMBL3391962 0.67 CACNA2D1 (0.61) SMN1; SMN2LMNANPSR1OPRD1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0311560-B1 Pigment compositions based on acetoacetarylides CIBA GEIGY AG (CH) 1995-10-25 — — EP claimed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 — — US claimed
Send feedback